ISIS PHARMACEUTICALS Stock Price
$22.59 
Change:
-0.38 -0.83% Volume:
51,988
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 22.99 | Todays Low: 22.45 | Open: 22.97 | Last Close: 23.07
52 Wk High: 24.04 | 52 Wk Low: 7.56 | Todays Pivot: 22.68 | Pre market open: 22.9
Sector: 
Online News For Isis Pharmaceuticals
|
ISIS PHARMACEUTICALS, INC. : Isis Pharmaceuticals to Present a General ... - 4-traders (press release)
Tue, 18 Jun 2013 11:07CARLSBAD, Calif., June 18, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a general corporate update in conjunction with its 2013 Annual Meeting of ...
|
|
Isis Pharmaceuticals Making Antisense - Seeking Alpha
Mon, 17 Jun 2013 21:28Isis Pharmaceuticals (ISIS) pioneers a drug development platform that targets specific mRNA strands, after transcription, and stops them from being translated into troublesome proteins. Despite its unfortunate name, antisense technology is an extremely ...
|
|
ISIS PHARMACEUTICALS, INC. : Xenon Licenses Antisense Drug XEN701 ... - 4-traders (press release)
Mon, 10 Jun 2013 11:10CARLSBAD, Calif. and VANCOUVER, British Columbia, June 10, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) and Xenon Pharmaceuticals Inc. announced today that Xenon has exercised its option to an exclusive worldwide license to ...
|
|
ISIS PHARMACEUTICALS, INC. : Isis Pharmaceuticals Earns $6 Million ... - 4-traders (press release)
Thu, 06 Jun 2013 11:12CARLSBAD, Calif., June 6, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has earned a $6 million payment from AstraZeneca related to continuation of the research collaboration between Isis and AstraZeneca to ...
|
|
Isis Pharmaceuticals' Management Presents at Goldman Sachs 34th Annual ... - Seeking Alpha
Thu, 13 Jun 2013 02:05So from – following on okay – from Isis Pharmaceuticals, she is the Chief Operating Officer and we encourage everyone to ask questions from the audience and – but prior to that, I have prior to starting our fireside chat, I have to read some ...
|
|
Isis Pharmaceuticals Announces Exercise of Underwriters' Option to Purchase ... - PharmiWeb.com (press release)
Mon, 03 Jun 2013 09:49CARLSBAD, Calif., May 31, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that the underwriters of its previously announced public offering of common stock, which was completed on May 14, 2013, have exercised their ...
|
ISIS Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Isis Pharmaceuticals quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for ISIS to choose from. Visit here to build your stock quote widget »
